Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | PF562271 | 0.000 | 0.000 | uM | 72 | hr | 2 | 19375 | 946 | 1.0025 | 1.0000 | 0.0488 | 0.0485 |
A-375 | Vemurafenib | PF562271 | 0.000 | 0.000 | uM | 72 | hr | 1 | 19613 | 936 | 1.0160 | 1.0000 | 0.0477 | 0.0485 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 1126 | 71 | 0.8418 | 0.7976 | 0.0631 | 0.0486 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 1047 | 45 | 0.7995 | 0.7976 | 0.0430 | 0.0486 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 981 | 39 | 0.7516 | 0.7976 | 0.0398 | 0.0486 |
A-375 | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 1292 | 66 | 0.0621 | 0.0577 | 0.0511 | 0.0487 |
MMAC-SF | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 901 | 34 | 0.6918 | 0.6184 | 0.0377 | 0.0487 |
MMAC-SF | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 630 | 33 | 0.4763 | 0.6184 | 0.0524 | 0.0487 |
MMAC-SF | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 2 | 912 | 51 | 0.6870 | 0.6184 | 0.0559 | 0.0487 |
A-375 | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 1130 | 64 | 0.0540 | 0.0577 | 0.0566 | 0.0487 |
A-375 | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 2 | 1173 | 45 | 0.0571 | 0.0577 | 0.0384 | 0.0487 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 3 | 591 | 30 | 0.5509 | 0.7915 | 0.0508 | 0.0491 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 2 | 854 | 49 | 0.7905 | 0.7915 | 0.0574 | 0.0491 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 1 | 1095 | 43 | 1.0331 | 0.7915 | 0.0393 | 0.0491 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 1 | 5745 | 285 | 0.3434 | 0.2974 | 0.0496 | 0.0491 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 2 | 5681 | 246 | 0.3419 | 0.2974 | 0.0433 | 0.0491 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 3 | 3476 | 189 | 0.2068 | 0.2974 | 0.0544 | 0.0491 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 2 | 755 | 33 | 0.7090 | 0.7182 | 0.0437 | 0.0494 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 3 | 563 | 36 | 0.5175 | 0.7182 | 0.0639 | 0.0494 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 1 | 985 | 40 | 0.9280 | 0.7182 | 0.0406 | 0.0494 |
WM-115 | Vemurafenib | I-BET | 0.100 | 0.000 | uM | 72 | hr | 3 | 3445 | 152 | 0.9446 | 0.9015 | 0.0441 | 0.0495 |
WM-115 | Vemurafenib | I-BET | 0.100 | 0.000 | uM | 72 | hr | 2 | 3375 | 186 | 0.9148 | 0.9015 | 0.0551 | 0.0495 |
WM-115 | Vemurafenib | I-BET | 0.100 | 0.000 | uM | 72 | hr | 1 | 3099 | 153 | 0.8451 | 0.9015 | 0.0494 | 0.0495 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 1 | 933 | 49 | 0.8681 | 0.6959 | 0.0525 | 0.0496 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 2 | 757 | 37 | 0.7070 | 0.6959 | 0.0489 | 0.0496 |